ASIA PACIFIC DIGITAL GENOME MARKET FORECAST 2021-2028

The Asia Pacific digital genome market is estimated to record a CAGR of 10.37%, over the forecast period of 2021 to 2028. The market growth of the region is accredited to chief factors, such as, the surging incidence of chronic conditions, the rising funding for genomics, the growing research and development, and the increase in genomics programs.

asia-pacific-digital-genome-market

The Asia Pacific digital genome market growth is assessed through the analysis of India, Japan, Vietnam, Thailand, South Korea, China, Australia & New Zealand, Indonesia, and the rest of the Asia Pacific. The Chinese government is highly supportive of genomics, due to which, the country’s key players significantly invest in genetic research. The development in China’s genomics research is fueled by key aspects like, the rising geriatric populace, the healthcare system’s substantial growth, and the increasing income of the country’s population. Moreover, the government of China has also mandated its citizen’s data banking, including their genomic data. 

On the other hand, South Korea harbors one of the best healthcare facilities, across the region. As a result, the country is capable of providing world-class healthcare to its population and medical tourists. The South Korean healthcare sector is administered by the Ministry of Health and Welfare and is free for its citizens. Moreover, the country also has an advanced healthcare infrastructure, with an efficient doctor to patient ratio and the latest equipment. Therefore, these factors are expected to facilitate the digital genome market growth in the Asia Pacific, over the forecast years.

Qiagen, headquartered in Germany, provides sample and assay technologies for molecular diagnostics, academic and pharmaceutical research, and applied testing. It operates in over 35 offices, across more than 25 countries. The company also offers molecular technologies delivered as kits with specific or open target analysis.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. INCREASING FUNDING BY THE MANUFACTURERS AND GOVERNMENTS IN GENOMICS
      2. ADVANCEMENTS IN TECHNOLOGY
      3. SURGING PREVALENCE OF CHRONIC DISEASES
    2. KEY RESTRAINTS
      1. RISKS ASSOCIATED WITH SECURITY ISSUE OF DIGITAL GENOME
      2. LACK OF PROFESSIONALS WITH ADEQUATE KNOWLEDGE ABOUT THE GENOMIC TECHNOLOGY
  1. KEY ANALYTICS
    1. PORTER’S FIVE FORCES ANALYSIS
      1. THREAT OF NEW ENTRY
      2. THREAT OF SUBSTITUTION
      3. BUYER’S POWER
      4. SUPPLIER’S POWER
      5. COMPETITIVE RIVALRY
    2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET
    3. OPPORTUNITY MATRIX
    4. VENDOR LANDSCAPE
    5. KEY INVESTMENT INSIGHTS
  2. MARKET BY PRODUCT
    1. SEQUENCING AND ANALYZER INSTRUMENTS
    2. DNA/RNA ANALYSIS
    3. SEQUENCING AND ANALYSIS SOFTWARE
    4. SEQUENCING CHIPS
    5. SAMPLE PREP INSTRUMENTS
  3. MARKET BY APPLICATION
    1. DIAGNOSTICS
    2. DRUG DISCOVERY
    3. ACADEMIC RESEARCH
    4. PERSONALIZED MEDICINE
    5. AGRICULTURAL
    6. OTHER APPLICATIONS
  4. MARKET BY END-USER
    1. DIAGNOSTICS AND FORENSIC LABS
    2. ACADEMIC RESEARCH INSTITUTES
    3. HOSPITALS
    4. OTHER END-USERS
  5. GEOGRAPHICAL ANALYSIS
    1. ASIA PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. CHINA
        2. JAPAN
        3. AUSTRALIA & NEW ZEALAND
        4. INDIA
        5. SOUTH KOREA
        6. THAILAND
        7. INDONESIA
        8. VIETNAM
        9. REST OF ASIA PACIFIC
  1. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGER & ACQUISITIONS
      2. PRODUCT LAUNCH & DEVELOPMENTS
      3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
      4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
    2. COMPANY PROFILE
      1. ABBOTT LABORATORIES
      2. AGILENT TECHNOLOGIES INC
      3. BECTON, DICKINSON AND COMPANY (BD)
      4. BIOMERIEUX SA
      5. BIO-RAD LABORATORIES INC
      6. HOFFMANN-LA ROCHE
      7. ILLUMINA INC
      8. INSCRIPTA
      9. OXFORD NANOPORE TECHNOLOGIES LTD
      10. PACIFIC BIOSCIENCE
      11. PERKINELMER INC
      12. QIAGEN NV
      13. REGENERON PHARMACEUTICALS
      14. THERMO FISHER SCIENTIFIC INC
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - DIGITAL GENOME

TABLE 2: ASIA PACIFIC DIGITAL GENOME MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: ASIA PACIFIC DIGITAL GENOME MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: ASIA PACIFIC DIGITAL GENOME MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: ASIA PACIFIC DIGITAL GENOME MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: ASIA PACIFIC DIGITAL GENOME MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: ASIA PACIFIC DIGITAL GENOME MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: ASIA PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: ASIA PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: LEADING PLAYERS OPERATING IN ASIA PACIFIC DIGITAL GENOME MARKET

LIST OF FIGURES

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: KEY INVESTMENT INSIGHTS

FIGURE 5: ASIA PACIFIC DIGITAL GENOME MARKET, BY PRODUCT, IN 2020

FIGURE 6: ASIA PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7: ASIA PACIFIC DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 8: ASIA PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 9: ASIA PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)

FIGURE 10: ASIA PACIFIC DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 11: ASIA PACIFIC DIGITAL GENOME MARKET, BY APPLICATION, IN 2020

FIGURE 12: ASIA PACIFIC DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 13: ASIA PACIFIC DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 14: ASIA PACIFIC DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 15: ASIA PACIFIC DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 16: ASIA PACIFIC DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION)

FIGURE 17: ASIA PACIFIC DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 18: ASIA PACIFIC DIGITAL GENOME MARKET, BY END-USER, IN 2020

FIGURE 19: ASIA PACIFIC DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)

FIGURE 20: ASIA PACIFIC DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 21: ASIA PACIFIC DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 22: ASIA PACIFIC DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 23: ASIA PACIFIC DIGITAL GENOME MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 24: CHINA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 25: JAPAN DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 26: AUSTRALIA & NEW ZEALAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: INDIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: SOUTH KOREA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: THAILAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: INDONESIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: VIETNAM DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: REST OF ASIA PACIFIC DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample